UBS, Shares

UBS Shares Under Pressure as Goldman Sachs Withdraws Buy Rating

06.02.2026 - 13:09:04

UBS CH0244767585

The turbulence surrounding UBS Group AG shows no sign of abating following a severe sell-off last Thursday. In a move that amplifies existing market skepticism, analysts at Goldman Sachs have rescinded their bullish stance on the Swiss banking giant. Investor concerns are now centered on substantial client outflows from its crucial US operations and intensified regulatory scrutiny from the Swiss Financial Market Supervisory Authority (FINMA), even as the bank attempts to attract shareholders with enhanced capital returns.

  • Rating Change: Goldman Sachs downgrades its recommendation from "Buy" to "Neutral."
  • Price Target: Reduced from 41.50 Swiss Francs to 38.00 Swiss Francs.
  • US Outflows: The wealth management unit reported net outflows exceeding USD 14 billion.
  • Regulatory Scrutiny: FINMA's head insists on significant increases to capital reserves.
  • Shareholder Returns: A 22 percent dividend hike is announced, alongside a planned share buyback program of up to USD 3 billion.

Regulatory Demands Cast a Long Shadow

Compounding the bank's operational challenges is a heated debate over its capital requirements. FINMA President Stefan Walter reiterated calls for stricter regulations on Thursday, defending proposals that could ultimately force UBS to hold up to an additional USD 26 billion in core capital.

Walter described the plans as "proportional," necessary to safeguard the financial system given the bank's increased systemic importance following its integration of Credit Suisse. For equity holders, this presents a dilemma: while aimed at mitigating risk, such a substantial capital reserve could potentially constrain the bank's long-term profitability and returns.

Goldman Sachs Steps Back Following Quarterly Results

Directly responding to the recent quarterly figures and the consequent erosion of market confidence, Goldman Sachs adjusted its position on UBS as the week closed. Analyst Chris Hallam lowered his rating on the shares to "Neutral," concurrently cutting the price target to 38.00 CHF.

This revision reflects heightened caution in the wake of the stock's steep decline, which saw it lose over 8 percent at one point during the previous trading session. Although Bank of America has maintained its buy recommendation, the shift by Goldman Sachs indicates that near-term positive catalysts are being overshadowed by mounting risks.

Should investors sell immediately? Or is it worth buying UBS?

Persistent Weakness in the American Market

A primary source of analyst hesitation stems from performance across the Atlantic. The bank's US Wealth Management division recorded alarming net new money outflows of more than USD 14 billion for the fourth quarter. Chief Financial Officer Todd Tuckner attributed this trend to changes in the unit's compensation model, which triggered the departure of a significant number of financial advisors.

The executive team anticipates continued headwinds in this segment through the first half of 2026. This operational softness hits the stock during an already fragile period; since the start of the year, UBS shares have declined by a total of 15.25 percent.

Solid Fundamentals Amidst a Clouded Outlook

Despite the wave of negative news, the full-year results contained several positive elements. A quarterly profit of USD 1.2 billion and the decision to raise the dividend to USD 1.10 per share demonstrate underlying financial strength. Furthermore, the announced share repurchase initiative, valued at up to USD 3 billion, is intended to provide support for a stock currently trading around 34.00 CHF.

For investors, the overall picture remains complex. The attractive shareholder returns are counterbalanced by unresolved issues in the US distribution network and the looming possibility of enforced capital retention. Whether the planned buybacks will be sufficient to durably halt the downward trend will likely depend on the operational performance revealed in the coming quarters.

Ad

UBS Stock: Buy or Sell?! New UBS Analysis from February 6 delivers the answer:

The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 6.

UBS: Buy or sell? Read more here...

@ boerse-global.de | CH0244767585 UBS